At ImaginAb, our goal is to create a completely new class of reagents for understanding pre-clinical biology and make imaging with biologics a same day clinical procedure in humans.  We reformat antibodies against biologically and clinically relevant targets into fragments optimized for diagnostic imaging.  We believe that in this era of targeted molecular therapy, there is a major unmet need for targeted in vivo diagnostics to help realize the promise of personalized medicine.